Wilson Sonsini is proud to co-sponsor a Healthcare Business Women's Association (HBA) speaker panel program.

As biotech innovation accelerates and global markets evolve, investors face growing challenges from an increasingly complex national security regulatory landscape. Regulatory scrutiny around foreign investment, data privacy, export controls, and intellectual property is intensifying, creating new risks that can significantly impact biotech deals. This presentation, led by Wilson Sonsini patents and innovations associate Alicia Umpierre, will provide an overview of the key regulations shaping the biotech investment landscape and offer practical guidance on how to navigate these challenges.

Presentation Topics include:

• Patent considerations for investors performing IP due diligence on start-ups
• Legislative updates

Register today to learn more about this topic and our ongoing collaboration with the HBA.